Global Research Network: Author Affiliations & Expertise
An ethical framework designed to guide the return of individual clinical trial data to participants has been formalized by the IMI FACILITATE Consortium, researchers announced this week. The framework, developed over several years, aims to establish a participant-centric approach to data sharing, addressing complex ethical and logistical challenges inherent in providing trial participants access to the data generated from their involvement in research.
The initiative, spearheaded by Ciara Staunton, Johanna M.C. Blom, and Deborah Mascalzoni, reflects a growing international movement toward greater transparency and participant empowerment in clinical research. Staunton, currently an independent consultant and Senior Researcher at the Institute for Biomedicine, Eurac Research, has been a key figure in developing the ethical guidelines. Her work extends to providing ethical and legal oversight on projects involving data science, AI, genomics, and biobanking, as well as serving on the National Irish COVID-19 Biobank – Research Ethics Committee.
The FACILITATE project, as outlined in an executive summary published in October 2025, recognizes the importance of returning individual participant data (IPD) but acknowledges the need for a robust ethical foundation to support this practice. The framework focuses on core ethical principles and provides practical guidance for implementation, covering areas such as informed consent, data security, and the potential for misinterpretation of complex scientific information.
According to a paper published in PubMed, the framework addresses the developing need for ethical considerations surrounding the return of clinical trial data. The authors emphasize the importance of decision-making processes and health data-sharing protocols. The consortium’s work builds upon existing recommendations for data sharing, including those outlined by Ohmann et al. In 2017, which established principles for sharing and reuse of IPD.
The framework’s development comes amidst increasing scrutiny of data access and usage in medical research. Staunton’s research, including her work on the implications of the General Data Protection Regulation (GDPR) for biobank and genetic research, highlights the legal complexities surrounding data sharing. She has also investigated challenges in accessing Italian databases for AI training, underscoring the practical hurdles to data utilization.
The FACILITATE Consortium includes researchers from multiple institutions, including the University of Modena and Reggio Emilia in Italy, the University of KwaZulu-Natal in South Africa, and the University Hospital Basel in Switzerland. Luca Pani, affiliated with both the University of Modena and the University of Miami, is also involved in the project. Melodie Labuschaigne, from the University of South Africa, contributes expertise in jurisprudence and legal frameworks.
The consortium has not yet released details regarding the specific mechanisms for implementing the ethical framework across different clinical trial settings. Further guidance is expected to address issues such as the format of data delivery, the level of support provided to participants in interpreting their data, and the procedures for addressing potential harms resulting from data access. The IMI FACILITATE Consortium has scheduled a follow-up meeting in the spring of 2026 to discuss implementation strategies.